We are live on ! Find out more
TC

Tavio Capital Portfolio holdings

AUM $75.4M
1-Year Est. Return 27.99%
This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+27.99%
3 Year Est. Return
+81.43%
5 Year Est. Return
10 Year Est. Return
AUM
$271M
AUM Growth
+$30.6M
Cap. Flow
+$3.25M
Cap. Flow %
1.2%
Top 10 Hldgs %
95.88%
Holding
16
New
1
Increased
3
Reduced
5
Closed
3

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$33.2M
2
LH icon
Labcorp
LH
+$26.3M
3
ZBH icon
Zimmer Biomet
ZBH
+$14.1M
4
PDCO
Patterson Companies, Inc.
PDCO
+$7.31M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZBH icon
1
Zimmer Biomet
ZBH
$17.6B
$48.5M 17.87%
391,170
+124,282
+47% +$14.1M
LH icon
2
Labcorp
LH
$23.1B
$47.5M 17.51%
361,457
+213,656
+145% +$26.3M
ELV icon
3
Elevance Health
ELV
$80.9B
$46.4M 17.08%
161,512
-17,264
-10% -$4.99M
CNC icon
4
Centene
CNC
$31.5B
$29.1M 10.72%
+547,575
New +$33.2M
MOH icon
5
Molina Healthcare
MOH
$11.7B
$24M 8.83%
168,867
-51,452
-23% -$6.96M
HCA icon
6
HCA Healthcare
HCA
$85.6B
$20.8M 7.65%
159,213
-60,770
-28% -$8.16M
UHS icon
7
Universal Health Services
UHS
$9.15B
$19.4M 7.15%
144,968
-53,479
-27% -$7.04M
PDCO
8
DELISTED
Patterson Companies, Inc.
PDCO
$11.1M 4.11%
510,054
+330,033
+183% +$7.31M
MEDP icon
9
Medpace
MEDP
$15.4B
$7.48M 2.76%
126,887
ZGNX
10
DELISTED
Zogenix, Inc.
ZGNX
$5.98M 2.2%
108,734
FOLD
11
DELISTED
Amicus Therapeutics
FOLD
$4.84M 1.78%
355,785
HRTX icon
12
Heron Therapeutics
HRTX
$90.1M
$4.06M 1.5%
166,024
-141,713
-46% -$3.71M
TVTX icon
13
Travere Therapeutics
TVTX
$5.27B
$2.29M 0.84%
100,985
COR icon
14
Cencora
COR
$59.9B
-116,687
Closed -$8.68M
CVS icon
15
CVS Health
CVS
$136B
-170,912
Closed -$11.2M
WCG
16
DELISTED
Wellcare Health Plans, Inc.
WCG
-114,337
Closed -$27M

Similar funds

Tavio Capital's Q1 2019 Portfolio in Review

As of Q1 2019, Tavio Capital held 16 positions worth $271M, up 13% from $241M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Tavio Capital's Q1 2019 filing shows 1 new, 3 increased, 5 reduced and 3 closed positions. Its largest new stake was Centene: 547,575 shares worth $29.1M. The largest sale was Wellcare Health Plans, Inc., an estimated $27M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 89% a quarter earlier.

  • Tavio Capital's largest Q1 2019 buy was Centene: 547,575 shares worth $29.1M.
  • Tavio Capital added most to Labcorp in Q1 2019, an estimated $26.3M increase.
  • Tavio Capital's biggest Q1 2019 reduction was HCA Healthcare, cutting an estimated $8.16M.
  • Tavio Capital fully exited Wellcare Health Plans, Inc. in Q1 2019, selling an estimated $27M.
  • Tavio Capital's ten largest holdings make up 96% of its $271M portfolio in Q1 2019.
  • Tavio Capital opened 1 new position and closed 3 in Q1 2019.
  • Tavio Capital's portfolio value rose 13% quarter-over-quarter to $271M.

Based on Tavio Capital's 13F filing for Q1 2019, filed 14 May 2019.